Literature DB >> 23404354

Additional decompression at adjacent segments leads to adjacent segment degeneration after PLIF.

Masayuki Miyagi1, Osamu Ikeda, Seiji Ohtori, Yoshikazu Tsuneizumi, Yukio Someya, Masataka Shibayama, Yasufumi Ogawa, Gen Inoue, Sumihisa Orita, Yawara Eguchi, Hiroto Kamoda, Gen Arai, Tetsuhiro Ishikawa, Yasuchika Aoki, Tomoaki Toyone, Toshio Ooi, Kazuhisa Takahashi.   

Abstract

PURPOSE: Adjacent segment degeneration (ASD) is one of the major complications of lumbar fusion. Several previous retrospective studies reported ASD after PLIF. However, few reports evaluated whether decompression surgery combined with fusion surgery increases the rate of complications in adjacent segments. The purpose of the current study was to investigate the degeneration in decompressed adjacent segments after PLIF.
METHODS: A total of 23 patients (12 men, 11 women; average age, 58.6) who underwent PLIF surgery [1 level (n = 9), 2 levels (n = 8), 3 levels (n = 4), 4 levels (n = 2)] were included. Additional adjacent decompression above or below the level of interbody fusion was performed at 25 levels and no adjacent decompression was performed at 15 levels. We retrospectively investigated ASD by X-ray films of all 40 adjacent segments (above and below fusion level) and clinical outcomes of all 23 cases.
RESULTS: Of the 40 adjacent segments, 19 (47.5%) showed ASD and 9 (22.5%) showed symptomatic ASD. In the 19 segments with ASD, ASD occurred in 16 of 25 (64.0%) segments at decompressed sites compared with 3 of 15 (20.0%) non-decompressed sites. The ratio of ASD in adjacent segments was significantly higher at decompressed sites than at non-decompressed sites (p < 0.01).
CONCLUSION: ASD occurs frequently in association with additional decompression above or below the level of PLIF. In cases in which the adjacent segments require decompression, a surgical strategy that preserves as much of the posterior complex as possible should be selected.

Entities:  

Mesh:

Year:  2013        PMID: 23404354      PMCID: PMC3731485          DOI: 10.1007/s00586-013-2694-8

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  44 in total

1.  Minimum 10-year follow-up study of anterior lumbar interbody fusion for isthmic spondylolisthesis.

Authors:  H Ishihara; R Osada; M Kanamori; Y Kawaguchi; K Ohmori; T Kimura; H Matsui; H Tsuji
Journal:  J Spinal Disord       Date:  2001-04

2.  Long-term follow-up study of posterior lumbar interbody fusion.

Authors:  S Nakai; H Yoshizawa; S Kobayashi
Journal:  J Spinal Disord       Date:  1999-08

3.  Adjacent-segment morbidity after Graf ligamentoplasty compared with posterolateral lumbar fusion.

Authors:  M Kanayama; T Hashimoto; K Shigenobu; M Harada; F Oha; Y Ohkoshi; H Tada; K Yamamoto; S Yamane
Journal:  J Neurosurg       Date:  2001-07       Impact factor: 5.115

4.  Anatomical and clinical studies on lumbar disc degeneration.

Authors:  S FRIBERG; C HIRSCH
Journal:  Acta Orthop Scand       Date:  1949

5.  Degenerative lumbar spinal stenosis: current strategies in diagnosis and treatment.

Authors:  Claudius Thomé; Wolfgang Börm; Frerk Meyer
Journal:  Dtsch Arztebl Int       Date:  2008-05-16       Impact factor: 5.594

6.  Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation.

Authors:  S D Boden; D O Davis; T S Dina; N J Patronas; S W Wiesel
Journal:  J Bone Joint Surg Am       Date:  1990-03       Impact factor: 5.284

7.  Risk factors for adjacent-segment failure following lumbar fixation with rigid instrumentation for degenerative instability.

Authors:  S Etebar; D W Cahill
Journal:  J Neurosurg       Date:  1999-04       Impact factor: 5.115

8.  AP-translation in the proximal disc adjacent to lumbar spine fusion. A retrospective comparison of mono- and polysegmental fusion in 120 patients.

Authors:  C Wimmer; H Gluch; M Krismer; M Ogon; R Jesenko
Journal:  Acta Orthop Scand       Date:  1997-06

Review 9.  Risk factors for adjacent segment degeneration after PLIF.

Authors:  Shin'ya Okuda; Motoki Iwasaki; Akira Miyauchi; Hiroyuki Aono; Masahiro Morita; Tomio Yamamoto
Journal:  Spine (Phila Pa 1976)       Date:  2004-07-15       Impact factor: 3.468

10.  Posterolateral lumbosacral fusion with transpedicular fixation: 63 consecutive cases followed for 4 (2-6) years.

Authors:  H Pihlajamäki; O Böstman; M Ruuskanen; P Myllynen; J Kinnunen; E Karaharju
Journal:  Acta Orthop Scand       Date:  1996-02
View more
  5 in total

1.  Risk factors for adjacent segment pathology requiring additional surgery after single-level spinal fusion: impact of pre-existing spinal stenosis demonstrated by preoperative myelography.

Authors:  Itaru Yugué; Seiji Okada; Muneaki Masuda; Takayoshi Ueta; Takeshi Maeda; Keiichiro Shiba
Journal:  Eur Spine J       Date:  2015-08-14       Impact factor: 3.134

2.  Effects of Concomitant Decompression Adjacent to a Posterior Lumbar Interbody Fusion Segment on Clinical and Radiologic Outcomes: Comparative Analysis 5 Years After Surgery.

Authors:  Tomiya Matsumoto; Shinya Okuda; Yukitaka Nagamoto; Tsuyoshi Sugiura; Yoshifumi Takahashi; Motoki Iwasaki
Journal:  Global Spine J       Date:  2018-10-08

3.  Risk factors for adjacent segment degeneration after posterior lumbar fusion surgery in treatment for degenerative lumbar disorders: a meta-analysis.

Authors:  Tao Wang; Wenyuan Ding
Journal:  J Orthop Surg Res       Date:  2020-12-03       Impact factor: 2.359

4.  Adjacent Segment Degeneration after Short-Segment Lateral Lumbar Interbody Fusion (LLIF).

Authors:  Jun Ouchida; Hiroaki Nakashima; Tokumi Kanemura; Yuji Matsubara; Kotaro Satake; Akio Muramoto; Kenyu Ito; Mikito Tsushima; Masayoshi Morozumi; Naoki Segi; Yoshinori Morita; Shiro Imagama
Journal:  Biomed Res Int       Date:  2022-03-24       Impact factor: 3.411

5.  MRI changes of adjacent segments after transforaminal lumbar interbody fusion (TLIF) and foraminal endoscopy: A case-control study.

Authors:  Shunmin Wang; Deyu Yang; Gengyang Zheng; Jie Cao; Feng Zhao; Jiangang Shi; Ruijin You
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.